Safety of long-term use of lisinopril for congestive heart failure
- 8 October 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (10) , 91-97
- https://doi.org/10.1016/0002-9149(92)91364-a
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- ACE Inhibitors — A Cornerstone of the Treatment of Heart FailureNew England Journal of Medicine, 1991
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- EnalaprilDrugs, 1989
- ACE Inhibitors in Congestive Heart FailureCardiology, 1989
- Safety Profiles of the Angiotensin-Converting Enzyme InhibitorsDrugs, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart FailureAnnals of Internal Medicine, 1987
- The Safety and Tolerability of Lisinopril in Clinical TrialsJournal of Cardiovascular Pharmacology, 1987
- Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failureAmerican Heart Journal, 1986
- ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRITThe Lancet, 1982